These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33104088)

  • 1. Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals.
    Moore D; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 Sep; 46(9):299-304. PubMed ID: 33104088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
    Young K; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.
    Gemmill I;
    Can Commun Dis Rep; 2015 Oct; 41(10):227-232. PubMed ID: 29769917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.
    Vaudry W; Stirling R;
    Can Commun Dis Rep; 2017 May; 43(5):96-103. PubMed ID: 29770072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
    Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
    Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the NACI Update on Herpes Zoster Vaccines.
    Warrington R; Ismail S;
    Can Commun Dis Rep; 2018 Sep; 44(9):220-225. PubMed ID: 31015813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine.
    Zhao L; Young K; House A; Stirling R; Tunis M
    Can Commun Dis Rep; 2021 Jun; 47(56):279-284. PubMed ID: 34220353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the NACI Seasonal Influenza Vaccine Statement for 2018-2019.
    Vaudry W; Zhao L; Stirling R
    Can Commun Dis Rep; 2018 Jun; 44(6):123-128. PubMed ID: 31015804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine recommendations for children and youth for the 2017/2018 influenza season.
    Moore DL
    Paediatr Child Health; 2018 Feb; 23(1):e10-e13. PubMed ID: 29479284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.
    Sinilaite A; Siu W; Papenburg J
    Can Commun Dis Rep; 2023 Oct; 49(10):406-412. PubMed ID: 38476927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.
    Andersohn F; Bornemann R; Damm O; Frank M; Mittendorf T; Theidel U
    GMS Health Technol Assess; 2014; 10():Doc03. PubMed ID: 25371764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination.
    Sinilaite A; Young K; Papenburg J
    Can Commun Dis Rep; 2023 Apr; 49(4):99-102. PubMed ID: 38298903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine recommendations for children and youth for the 2018/2019 influenza season.
    Moore DL
    Paediatr Child Health; 2018 Dec; 23(8):565-566. PubMed ID: 31043846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live versus attenuated influenza vaccine uptake and post-vaccination influenza-like illness outcomes in HIV-infected US Air Force members.
    Menegay JL; Xu X; Sunil TS; Okulicz JF
    J Clin Virol; 2017 Oct; 95():72-75. PubMed ID: 28889083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
    King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
    Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?
    Tam TWS
    Paediatr Child Health; 2018 Feb; 23(1):31-34. PubMed ID: 29479277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the NACI Seasonal Influenza Vaccine Statement for 2019-2020.
    Zhao L; Young K; Gemmill I
    Can Commun Dis Rep; 2019 Jun; 45(6):149-155. PubMed ID: 31285706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.